What's New in Health and Life Sciences
News from the European Comission
EUROPA - Research and Innovation: Health & Life Sciences
EUROPA - Research What's New in Health and life sciences. This RSS feed includes the most recent updates to the European Commission's Research and Innovation web site on Europa in the area of Health and life sciences. The last (or, in some news readers, the first) item of this feed will take you to the Health web site. For more RSS news feeds visit http://ec.europa.eu/research/index.cfm?pg=rss
For more RSS news feeds click the link above.
Any surgical procedure can be risky, especially for older people. To minimise the dangers, EU-funded researchers have developed the world's first personalised test to assess the risk of patients developing post-surgical sensory and cognitive disorders, allowing doctors to choose the safest treatment.
Using neurons grown from stem cells, EU-funded researchers are revealing more about mutations that lead to autism, schizophrenia and intellectual disability which researchers hope will lead to new drug targets for personalised medicine.
EU-funded researchers are investigating the causes and consequences of ADHD with the aim of improving the lives of patients and reducing their risk of developing linked disorders such as depression and obesity.
The Nobel Prize in Physiology or Medicine for 2019 has been awarded jointly to William G. Kaelin Jr, Sir Peter J. Ratcliffe and Gregg L. Semenza for their discoveries of how cells sense and adapt to oxygen availability.
WHO reports show that more than 3 million people died from alcohol-related illness in 2016, yet low-cost interventions to measure how much people drink can lead to major reductions in heavy consumption. The EU-funded SCALA project promises significant results by introducing some of these techniques in Latin America.
Older people recovering from cardiac problems regularly miss out on life-changing rehabilitation. An EU-funded project has harnessed new technology to include this often-forgotten population.
Researchers have long struggled to study sudden cardiac arrests that take place outside of hospitals. An ongoing EU-funded project is harmonising research from across Europe to bring clarity to this complex disease.
Innovative biomedical technologies and biomaterials developed in an EU-funded project promise to improve the quality of life for millions of people suffering from type 1 diabetes, eliminating the need for regular insulin injections.
EU and industry funded researchers are shedding light on genes that influence the progression of Alzheimer's disease, paving the way for the development of novel drugs and therapeutic strategies that could delay or slow cognitive decline.